MedPath

Astigmatism Post-trabeculectomy

Completed
Conditions
Glaucoma
Registration Number
NCT01711190
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

The aim of this project:

1. Confirming the modification in corneal astigmatism after trabeculectomy with MMC and intracameral administration of bevacizumab.

2. Medium-term follow up (6 months) of the induced corneal astigmatism.

3. Investigating correlations between postoperative astigmatism, particularly with the postoperative IOP.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Primary open angle glaucoma
  • Normal tension glaucoma
  • Pseudoexfoliation glaucoma
  • Pigment dispersion glaucoma
Exclusion Criteria
  • Patients who refuse to sign the informed consent.
  • Patients with primary angle closure glaucoma (PACG).
  • Patients younger than 18 years old.
  • Other ocular diseases besides glaucoma.
  • Significant corneal opacities.
  • Refractive error more than + or -6.00 diopters.
  • Visual acuity less than 0.05
  • Previous intra-ocular surgery (except cataract surgery more than six months preceding the trabeculectomy).
  • Laser treatment for glaucoma within 6 months of the surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in ocular cylinder and axis untill 6 months after trabeculectomy.pre-operative until 6 months post-operative

Comparing the change in corneal cylinder, axis and IOP before the operation and 1,3 and 6 months after the operation. We will compare these vectors by vector analyses.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sint-Raphaël hospital

🇧🇪

Leuven, Vlaams-Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath